Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Agus
AddedFeb 13, 2024
UpdatedMay 31, 2026
David Agus

David Agus

Board Member, Thrive Global

CrunchbaseThe Org

David Agus's Career

Thrive Global
Thrive Global

New York City, NY, US

Board Member· Board
Olive
Olive

Columbus, OH, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Agus's Career

Thrive Global
Thrive Global
Series C$145.9M9562016New York City, NY, US
Board Member· Board

Recent news

InScope nabs $14.5M to solve the pain of financial reportingTechCrunch · 2026
Hear from Sequoia Capital and Kleiner Perkins this week on TechCrunch LiveTechCrunch · 2023

Leadership at Thrive Global

Arianna HuffingtonArianna HuffingtonFounder
Somesh DashSomesh DashBoard Member
Lloyd MinorLloyd MinorBoard Member
Paul HsiaoPaul HsiaoBoard Member
Fred HarmanFred HarmanBoard Member
Ian ChiuIan ChiuBoard Member

Similar to Thrive Global

ThriveStreamsThriveStreamsNew York City, NY, USSoftwareest. 2012ThriveStreamsNew York City, NY, US · est. 2012

ThriveStreams: Innovating in Positive Technology to empower human potential and wellbeing.

Seed · $20k5
HappifyHappifyNew York City, NY, USDigital Therapeuticsest. 2012HappifyNew York City, NY, US · est. 2012

Happify Health: Personalized digital therapeutics and modern healthcare solutions provider.

Series D · $118.7M175
Thrive SoftwareThrive SoftwareBaltimore, MD, USSoftware Solutionsest. 2018Thrive SoftwareBaltimore, MD, US · est. 2018

Thrive Software: Developing efficient, impactful software solutions, founded by innovative leaders.

Seed · $900k7
Woebot HealthWoebot HealthSan Francisco, CA, USMental Health, Therapyest. 2017Woebot HealthSan Francisco, CA, US · est. 2017

World's first AI-powered mental health ally, Woebot Health, offers personal growth tools for individuals and businesses.

Series A · $123.3M139
Olive
Olive
Acquired$856.3M02012Columbus, OH, US
Board Member· Board

Leadership at Olive

Eileen NaughtonEileen NaughtonBoard Member
Keith RaboisKeith RaboisBoard Member
Ronald PaulusRonald PaulusBoard Member
George BarrettGeorge BarrettBoard Member
Chris OlsenChris OlsenBoard Member
Billy DeitchBilly DeitchBoard Member

Similar to Olive

OliveOliveVancouver, British Columbia, CASoftwareest. 2018OliveVancouver, British Columbia, CA · est. 2018

Streamlining software selection for digital transformation through our all-in-one app.

Seed · $4.3M34
OlioOlioIndianapolis, IN, USCollaboration Platformest. 2017OlioIndianapolis, IN, US · est. 2017

Olio: A unique digital platform connecting acute and post-acute providers by specialty.

Series A · $15.5M69
Olli.aiOlli.aiNew York City, NY, USAI Insights, Data Platformest. 2021Olli.aiNew York City, NY, US · est. 2021

AI data platform providing insights through queries. Founded in 2021, based in New York.

Angel30
Ori.aiOri.aiWashington, D.C., DC, USPatient Engagementest. 2016Ori.aiWashington, D.C., DC, US · est. 2016

Ori: An AI-powered healthcare startup revolutionizing patient care through mobile messaging.

Seed · $600k2

David Agus's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to David Agus

Louis AronneLouis AronneCo-Founder · IntellihealthOwen WitteOwen WitteBoard Member · Allogene TherapeuticsCharles SchleienCharles SchleienBoard Member · Northwell HealthMitchell BluttMitchell BluttBoard Member · Consonance CapitalLarry BrilliantLarry BrilliantBoard Member · SalesforceSteven FlanaganSteven FlanaganBoard Member · NYU Grossman School of Medicine